Dietary interventions can improve clinical outcomes for some women with breast cancer
the ONA take:
Data from the Women’s Intervention Nutrition Study (WINS) presented at the San Antonio Breast Cancer Symposium demonstrated that reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
The WINS was a randomized trial, to which 2,437 women ages 48 to 79 years were recruited. The women had early stage hormone-unrelated breast cancer, receiving standard-of-care treatments at 39 centers in the United States. They were randomly assigned to follow a dietary intervention that reduced their fat intake for 5 years following diagnosis (975 patients) or to a control group (1,462 patients).
Centrally trained, registered dietitians implemented the low-fat eating plan via eight biweekly individual counseling sessions and subsequent contacts every 3 weeks, plus unannounced 24-hour telephone recalls performed annually. In addition, the women self-monitored and recorded their fat intake in a book. After more than 15 years of follow-up, death rates from all causes in the intervention group were significantly lower than in the control group.
“The dietary intervention was supported for a median of 5 years,” the researchers reported. Based on their findings, however, the researchers suggest that for lifestyle interventions to have a long-term influence on clinical outcomes, they must be lifelong changes rather than short-term interventions.
Reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|